| Literature DB >> 31979139 |
Omowumi T Kayode1, Damilare E Rotimi1, Abolanle A A Kayode2, Tomilola D Olaolu1, Oluyomi S Adeyemi1.
Abstract
Reproductive dysfunction is often characterized by malfunction of the reproductive tissues, which may lead to disruption of the synergistic rhythm that should bring about a progression of sexual events and the conception of new life. This may therefore result in the sexual dysfunction and infertility that can be seen in couples having prolonged biological difficulty in reproducing their offspring after having unrestricted sexual intercourse for at least twelve months. Several factors have been implicated in the cause and progression of reproductive dysfunction, including poor nutrition, drug side effects, disease states, and toxicant ingestion. A well-known food additive that has been found to be potent at initiating reproductive anomalies in males is monosodium glutamate (MSG). This regular flavor enhancer is widely used as a taste enhancer in several diets. The different mechanisms by which it may induce reproductive dysfunctions include spermatogenic alteration resulting in a low sperm count, high sperm abnormality, reduced live sperm and decreased sperm pH, oxidative damage (increased lipid peroxidation and reduced antioxidant enzyme activities), histological alteration (blood hemorrhage, distorted germ and Sertoli cells), as well as gonadotropin imbalance (reduced testosterone, luteinizing hormone, and follicle-stimulating hormone concentrations). Therefore, this review discusses various established mechanisms through which MSG may induce reproductive dysfunction and the treatment strategies to ameliorate its toxic effects.Entities:
Keywords: antioxidant enzymes; monosodium glutamate; reactive oxygen species; reproductive dysfunction; sperm quality; testosterone
Year: 2020 PMID: 31979139 PMCID: PMC7151728 DOI: 10.3390/toxics8010007
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Reproductive injury induced by monosodium glutamate (MSG) administration to laboratory animals.
| Serial number | MSG Induced Alteration | Animal Type and Average Body Weight | Days of Administration and Type | Number of Animals and Dosages | Authors |
|---|---|---|---|---|---|
| 1 | Increased body weight; decreased sperm concentration, motility, and viability; | Albino rats 150 g | 90 days Oral | 20 rats: 4 (5/group) | [ |
| 2 | Testicular histological changes in germinal epithelium and Leydig cells (hypertrophied); | Neonate | 75 days Subcutaneous | 14 mice | [ |
| 3 | Decrease in weight of testis, epididymis, seminal vesicle and prostate; | Wistar rats 180 g | 120 days Subcutaneous | 18 rats: 2(9) | [ |
| 4 | Increased SOD level in epididymis, prostate gland, and seminal vesicle; | Sprague Dawley Rats 170–200 g | 28 days Oral | 24 rats: 3 (8/group) | [ |
| 5 | Testicular morphological alteration; | Sprague Dawley male rats | 30 days (twice a day) | 32 rats: 4 (8/group) | [ |
| 6 | Decreased epididymal sperm count; | Sprague Dawley rats 160–180g | Oral 42 days (every 48 h) | 28 rats: 4 (7/group) | [ |
| 7 | Decrease in sperm count and abnormal sperm morphology; | Wistar male rats | 14 days intraperitoneal | 24 rats: 4 (6/group) | [ |
* Groups showing the observed effects. GSH: reduced glutathione; MDA: malondialdehyde; SOD: superoxide dismutase.
Treatment options to ameliorate MSG-induced reproductive tissue alterations.
| Serial number | Effect of MSG and Treatment | Animals Used and Body Weight | Days of Administration and Type | Number of Rats and Dosages | Authors |
|---|---|---|---|---|---|
| 1 | Histological alterations (blood hemorrhage, distorted germ cells, and few Sertoli cells) | Albino rats 120–150 g | 4–8 weeks Oral | 48 rats: 4 (12/group) | [ |
| 2 | Reduced testis and epididymis weight | Albino rats | 65 days | 30 rats: 5(6/group) | [ |
| 3 | Reduced testicular antioxidant activities | Wistar rats | 28 days Oral | 40 rats: 4 (10/group) | [ |
| 4 | Increased oxidative stress (MDA) | Wistar rats 150–200 g | 30 days Oral | 120: 12 (10) rats | [ |
| 5 | Decreased body and testis weight | Rabbits | 12 weeks Oral | 20 rats: 4 (5/group) | [ |
| 6 | Low testosterone and follicle-stimulating hormone (FSH) level | Wistar rats 120 ± 20 g | 8 weeks Intraperitoneal | 60 rats: 6 (10/group) | [ |
| 7 | Decreased testis weight and sperm count | Sprague Dawley rats 140 ± 5 g | Oral | 65 rats in total | [ |
Figure 1Mechanism of MSG-induced testicular alterations.